US Stock MarketDetailed Quotes
NYXH Nyxoah SA
- 9.400
- -0.194-2.03%
Close Oct 31 16:00 ET
351.46MMarket Cap-5831P/E (TTM)
9.670High9.390Low9.85KVolume9.670Open9.594Pre Close93.67KTurnover0.06%Turnover RatioLossP/E (Static)37.39MShares20.00052wk High2.69P/B152.40MFloat Cap4.00052wk Low--Dividend TTM16.21MShs Float37.000Historical High--Div YieldTTM2.92%Amplitude4.000Historical Low9.513Avg Price1Lot Size
About Nyxoah SA Company
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
Company Profile
SymbolNYXH
Company NameNyxoah SA
Listing DateJul 2, 2021
Issue Price27.00
Founded2009
CEOMr. Olivier Taelman
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
AddressRue Edouard Belin 12
CityMont-Saint-Guibert
ProvinceWalloon Region
CountryBelgium
Zip Code1435
Phone32-10-22-23-55
Websitehttp://www.nyxoah.com
Company Executives
- Name
- Position
- Salary
- Olivier Taelman
- Chief Executive Officer and Director
- 807.10K
- Loic Moreau
- Chief Financial Officer
- 468.69K
- Robert Taub
- Non-Executive Chairman of the Board
- 127.63K
- Dr. Pierre Gianello, M.D.
- Director
- 175.63K
- Rita Johnson-Mills
- Independent Director
- 63.62K
- Kevin Rakin
- Independent Director
- 68.59K
- Dr. Jurgen Hambrecht, PhD
- Independent Director
- 58.50K
- Daniel George Wildman
- Independent Director
- 71.28K
- Virginia M. Kirby
- Independent Director
- 59.22K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data